DKK1 and breast carcinoma: There are significant limitations to this current study, including the small data set, few cases of stage I patients, no validation in an independent series of cases, categorize the accumulation of DKK1 and beta-catenin in breast cancers by immunohistochemical to positive and negative rather than scoring.